Professional Documents
Culture Documents
Origin
The following financial report analysis is based on three companies- Beximco Pharma, Square
Pharmaceuticals Limited and Renata Limited. All these three companies are well known
pharmaceuticals companies in the todays market of Bangladesh. This report is prepared for Mrs.
Dilara Afroz Khan (DAK), instructor of the course FIN 254 (Introduction to Financial Management)
for the fall semester 2006 as a partial requirement of the course.
Objective
The objective of this report is to analyze the scenario of these three companies as well as
gathering practical knowledge from the financial context and establish a relation with our
knowledge of the course. A key objective is to conduct a ratio analysis, developing common size
income statement of the companies and evaluate their performances by generating industry
averages or industry standard values. To evaluate their performances against the industry
standard values we have used the Do Pont System to analyze the ratios. The project includes
application of various ratio formulas to find out the ratios required to understand the financial
situation of the companies in comparison to the industry average.
Methodology
Before gathering all the information, we generated a clear and precise strategy to work. First we
collected the Annual report of the companies for the year 2005. Then the ratios and industry
standard values are generated using Microsoft Excel. Afterwards, the original reports are
common sized using the format of our book ( Principles of Managerial Finance,
Lawrence J.Gitman). Finally, through implementing our learning in the course, the analysis
part was done.
Scope
This report focuses on the various ratios under the criterion of liquidity, profitability, asset
management, debt management, market value which are generated on the financial
performances of the Pharmaceuticals Companies naming- Beximco Pharma, Square
Pharmaceuticals Limited and Renata Limited from Dhaka Stock Exchange of the year 2005.
Limitation
The contents of the report are exclusively obtained from the annual reports and our learning in
the course FIN 254. Therefore, the analysis part reflects our limited knowledge about the vast
financial world. Furthermore, the assumptions made about various situations can be different
from what it is in the real world. So, the content of the report may vary slightly from reality and the
analysis in the report may not fully reflect the actual situation of the companies.
Source of Data
The information provided in this report was collected in several ways. We collected the annual
report from people in parental level and other essential information was collected from the
Internet. Finally, they were manipulated with the help of the contents of our book.
RATIO CALCULATIONS
Workings:
All the calculations are done for the ratio shown in below:
Liquidity Ratios
1. Liquidity Ratio = Current Asset/Current Liabilities (Current Asset and Current Liabilities are
taken from balance sheet)
2. Quick or Acid Ratio = Current Asset-Inventories/Current Liabilities (Current Asset,
Inventories, Current Liabilities are taken from balance sheet)
Profitability Ratios
10. Gross Profit Margin = Sales Cost of goods sold/ Sales (Sales or Turn over and Cost of
goods sold are taken from Income statement)
11. Operating Profit Margin = Operating Profits / Sales (Sales and Operating Profits are taken
from Income statement)
12. Net Profit Margin = Earnings Available for Common stockholders/ Sales (Sales and
Earnings available for common stockholders are taken from Income Statement)
13. Earnings per Share = Earnings Available for common stockholders/ Numbers of Shares of
common stock outstanding. (EACSH is from income statement and No. Of common stock
is from Balance sheet)
14. Return On Total Assets = Earnings Available for common stockholders /Total Assets
(EACSH is taken from Income sheet and Total Asset is taken from balance sheet)
15. Return On Equity = Earnings Available for common stockholders /Common Stock Equity
(EACSH is taken from Income sheet and Common stock Equity is taken from balance
sheet)
Industry
Ratio
BEXIMCO
SQUARE
RENATA
Average
Liquidity
Current Ratio
Quick Ratio
1.40
0.72
1.78
1.19
1.75
0.74
1.64
0.88
Activity
Inventory Turnover
Average Collection Period
Average Payment Period
Total Asset Turnover
1.05
84.38
92.83
0.30
2.63
14.67
7422.43
0.76
2.13
36.31
103.74
1.26
1.94
45.12
2539.67
0.78
Debt
Debt Ratio
Times Interest Earned Ratio
Fixed-Payment Coverage Ratio
0.38
3.26
2.54
0.31
11.30
3.65
0.39
13.78
5.82
0.36
9.45
4.00
Profitability
Gross Profit Margin
Operating Profit Margin
Net Profit Margin
Earnings Per Share (EPS)
Return On Total Assets (ROA)
Return On Common Equity
0.47
0.22
0.15
6.36
0.04
0.36
0.22
0.16
234.67
0.13
0.48
0.20
0.12
239.71
0.15
0.44
0.21
0.14
160.25
0.11
(ROE)
0.09
0.27
0.25
0.20
Market
Price/Earnings (P/E) Ratio
Market/Book (M/B) Ratio
9.09
0.83
0.40
0.11
0.42
0.11
3.30
0.35
RATIO ANALYSIS
Liquidity Ratios
The liquidity of a firm is measured by its ability to satisfy short-term obligations. Two basic
measures are Current and Quick ratio.
Current Ratio
The current ratio measures the firms ability to meet its short-term obligations. The higher a firms
current ratio, the more liquid a firm is considered to be.
The industry average for the three pharmaceuticals companies is 1.64.
For Beximco Pharma, we found that, current assets recorded Tk.3495849163, and current
liabilities of Tk.2501824568. Thus the current ratio calculated is 1.40. Compared to industry
average, liquidity of Beximco Pharma is little bit low. This indicates problem within the companys
cash management system.
For Square Pharmaceuticals Limited, we found that, current assets recorded Tk.4031684955,
and current liabilities of Tk.2260755481. Thus the current ratio calculated is 1.78. Compared to
the industry average, Square Pharmaceuticals Limited is very liquid. Still its higher from the
industry average, so the company may hold excessive cash, account receivable or inventory.
For Renata Limited, we found that, current assets recorded Tk.672355277, and current liabilities
of Tk.384140329. Thus the current ratio calculated is 1.75. Compared to industry average, the
liquidity is good enough. That means companys cash management system is working good.
Activity Ratios
Activity ratios measure the speed with which various accounts are converted into sales or cashinflows or outflows
Inventory Turnover
Inventory turnover commonly measures the activity, or liquidity, of a firms inventory.
The industry average for textile mills in Bangladesh is 1.94.
For Beximco Pharma, Cost of Goods Sold is Tk.1768522363. So, inventory turnover is 1.05. As it
is lower than the industry average, so the inventory management of the company is not working
well.
For Square Pharmaceuticals Limited, Cost of Goods Sold is Tk.3525402669. So, inventory
turnover is 2.63. As it is more than the industry average, the firm is operating fairly. But still the
company may have lower level of inventory which may cause stock outs and lost sales.
For Renata Limited, Cost of Goods Sold is Tk.829197436. So, inventory turnover is 2.13. So it is
also higher than the industry average. This indicates companys operations are working smoothly
but they may have lower level of inventory.
Debt Ratios
It indicates the amount of other peoples money being used to generate profits.
Debt Ratio
This ratio measures the proportion of total assets financed by the firms creditors.
The industry average for Bangladesh textile industry is 0.36.
10
Debt Ratio for Beximco Pharma is 0.38. It is close to the industry average but still higher. The
firm thus has a high degree of indebt ness and more financial leverage
Debt Ratio for Square Pharmaceuticals Limited is 0.31. It is lower than the industry average. This
indicates that the company has financed a low portion of its assets with its debt. Thus the
company has more scope to look for funds from investors.
Debt Ratio for Renata Limited is 0.39. It is also higher than the industry average but close to it.
Infact, this company has more debts compared to other firms.
Profitability Ratios
11
There are many measures of profitability. As a group these measures enable the analyst to
evaluate firms profits with respect to a given level of sales, a certain level of assets, or the
owners investment.
12
The net profit margin for Square Pharmaceuticals Limited is 16%. This is higher than the average.
Comparing to other companies, it profits more.
The net profit margin for Renata Limited is 12%. This is lower than the average. So, the company
should look for more profit.
13
ROE for Square Pharmaceuticals Limited is 27%. So, it provides higher returns on assets.
ROE for Renata Limited is 25%. It is higher than the average. So, it has greater profitability.
Market Ratios
Market ratios relate a firms market value, as measured by its current share price, to certain
accounting values.
14
Beximco
Square
Renata
Sales revenue
Less: Cost Of Goods Sold (COGS)
Gross Profit Margin
100.00%
53.16%
46.84%
100.00%
49.75%
36.19%
100.00%
51.55%
48.45%
25.07%
21.49%
13.89%
11.26%
29.80%
16.39%
3.33%
0.25%
25.07%
21.77%
2.39%
0.23%
13.89%
22.30%
13.11%
0.30%
29.80%
19.70%
6.67%
14.59%
0.12%
14.71%
1.03%
13.67%
1.97%
21.64%
5.18%
16.45%
2.87%
13.58%
1.43%
17.37%
5.40%
11.97%
1.00%
10.97%
DU PONT SYSTEM
15
ROE =
=
Analysis
Beximco Pharma
ROE (9%) = ROA (4%) * FLM (2.25)
A low ROE that results from a low ROA reflects significant problem in the total asset turnover.
Comparing it with the industry average we can conclude a major problem of sales.
16
Though ROE and ROA is quite better off compared to the industry, ROA is quite low compared to
other profitable companies. This suggests a problem in total asset turnover, which indicates a
huge stock of assets. The company is in stocking more assets than they require.
Renata Limited
ROE (25%) = ROA (15%) * FLM (1.67)
A comparatively low ROA points out low net profit margin. This is the result of low earnings
available for common stock holders and sales compared to other profitable companies.
CONCLUSION
17
Beximco, Square Pharmaceuticals and Renata are three of the most popular companies in the
pharmaceutical industry of Bangladesh. By carrying out a ratio analysis of these companies, we
ere able to get an inside overview of the operation of the firm and match them with their
reputation. Clearly each company is distinct in setting their operation policies and matching the
expectations of the stockholders. There are still many changes to hope for in these companies as
time puts new challenges in front of them.
Suggestions
18
After completing the analysis part we have recommended some suggestions, which they may
follow:
1. Beximco Pharma should try and increase its quality and thus increase sales. Beximco
Pharma policies should be considered to increase ROE and thus attract more stockholders.
2. Asset management of Square Pharmaceuticals Limited should be improvised to meet the
requirements. This will help them to solve their problems.
3. Company should focus in increasing their sales and earnings available to common stock
holders.
Nothing goes completely with books. Infact, practical scenario is naturally much more
complicated. In the future, when we will enter the commercial life, we have to relate our
knowledge with the practical scenario. This project is opportunity to practice such kind of
activities. This project gave us an opportunity to learn several important aspects about the finance
of a company. Through this project we have learned several financial processes like how to
prepare common size income statement and calculate ratios from the figures of the companys
balance sheet and income statement. We have also learned to evaluate financial ratios to analyze
and monitor a firms performance. Thus we succeed to relate the practical scenario with the
contents of our textbook.
19